US Stock MarketDetailed Quotes

Aytu BioPharma (AYTU)

Watchlist
  • 2.190
  • -0.080-3.52%
Close May 15 16:00 ET
  • 2.190
  • 0.0000.00%
Post 16:10 ET
23.51MMarket Cap-0.65P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aytu BioPharma (AYTU) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q2
Stock NameRevenueRatio
Attention Deficit Hyperactivity Disorder (ADHD) Portfolio13.22M87.15%
Pediatric Portfolio1.69M11.14%
EXXUA241K1.59%
Other19K0.13%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States66.38M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -